Pharmaceutics / Medical Equipment

A Finnish SME, established 2005, develops and manufactures high quality diagnostic products and services especially for multianalyte and rapid diagnostics of acute infections. The test panels cover viruses and bacteria for most common acute upper and lower respiratory infections. The SME already exports to 15 countries globally, but it pursues new markets, more extensive distributor network, and fast growth. In its domestic market in Finland, the SME is a clear market leader in its own segment. 75% of the largest Finnish private healthcare providers rely on the SME’s service and technology. The technology is field proven, with high customer satisfaction. The product is the most sophisticated solution in the market for automated multidisease testing of acute infections. Based on the developed technology, the SME has also developed a platform and solution for pharmacies and minute clinics to start offering professional respiratory infection testing directly to consumers. It enables new operators to offer near-patient testing services for communities and the common public. It provides the operators with a significant business opportunity by bringing new customers and more sales for existing customers. The partnering model is the franchise agreement: The company is looking for pharmacy chains or retailers, online doctor services or minute clinic chains, or other healthcare service providers to become franchisees. Advantages and innovations: The concept is an affordable and low-threshold testing service for communities and the common public. The service minimizes the risk of infecting others or getting infected yourself. The tests help to identify the pathogen and enable the doctor to prescribe the appropriate treatment which can speed up recovery, reduce contagiousness, or prevent infection in close contacts. Expected role of a partner: The searched partner should act as a franchisee providing testing services for communities and the common public.